Axxess Pharma, Inc., a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products has announced that their Ontario and Vancouver manufacturing locations and facilities are now operating in full force following the successful 3 year annual inspection by Health Canada.
This successful inspection comes following Axxess Pharma’s most recent Letter of Intent (LOI) to acquire a Canada-based pharmaceutical manufacturer. This location generates over $2 million in annual revenues to Axxess Pharma, Inc.’s financials.
The company’s facility is roughly 22,000 square feet and manufactures pharmaceuticals, neutroceuticals and dermatologicals. Axxess Pharma will continue the distribution of its own line of pharmaceuticals from its Markham location.
“We are very excited to receive approval from Health Canada. Our facilities are now in place to process and manufacture all orders worldwide. In recent months we have signed exclusive license agreements in Latin America, Africa, Middle East and Canada with non-exclusive sales in the United States and various other countries,” stated Gerald Sequeira, President/CEO. “This is one more sign that we are focused on continuing to expand our operations across Canada and gain market share,” stated Gerald Sequeira, President/CEO.
